Clinical Trials Browser

Withdrawn × Interventional × Pleural Effusion, Malignant × Clear all

NCT05375825 2024-02-02

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Phase 1 Withdrawn

MyeloidOther solid neoplasmThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Mesothelioma, Malignant, Carcinoma, Pleural Effusion, Malignant

NCT02975921 2019-01-11

Betadine Pleurodesis Via Tunneled Pleural Catheters

Phase 4 Withdrawn

Bronchiolitis Obliterans Syndrome, Pleural Effusion, Pleural Effusion, Malignant

NCT00005645 2018-09-18

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Phase 2 Withdrawn

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant